IRCT20180224038841N1招募中2 期
Comparing the effect of Dimethyl fumarate and Placebo on infarct size and NIHSS score in acute ischemic stroke patients
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 85 years（—）
- 性别
- All
入选标准
- •Patients at the age of 18-85 years old
- •Patients with acute neurological symptoms who have been diagnosed as ischemic stroke by a neurologist
排除标准
- •Patients with prior sensitivity to dimethyl fumarate
- •Patients with serious infections
- •Pregnancy and lactation
- •Immunologic deficiencies in the past 6 months (i.e. cancer,lymphoma, HIV and viral hepatitis)
- •Patients receiving rtPA
- •Patients who undergo endovascular treatment
- •Liver function test more than 2 times of normal range
- •Initial WBC count under 3500
- •lymphopenia under 500
研究者
相似试验
招募中
3 期
Efficacy of dimethyl fumarate administration vs placebo on neurosurgical brain induced injury measured by S100 beta protein concentration and performance (Karnofsky scale) among glioblastoma multiform patientGliobalstom multiforme.Malignant neoplasm of brain, unspecifiedC71.9IRCT20200226046624N1Tehran University of Medical Sciences72
招募中
1 期
Effect of dimethyl fumarate administered to patients with adrenomyeloneuropathy: a multicenter, placebo controlled, phase IIb/III trialAdrenomyeloneuropathyCTIS2023-506795-27-00Fundacio Institut D Investigacio Biomedica De Bellvitge IDIBE40
进行中（未招募）
1 期
Dimethylfumarate for the treatment of Palmoplantar PustulosisPalmoplantar PustulosisMedDRA version: 20.0Level: LLTClassification code 10050185Term: Palmoplantar pustulosisSystem Organ Class: 100000004858EUCTR2017-003386-10-ATMedical University of Vienna25
尚未招募
不适用
Bioequivalence study of dimethyl fumarate 240 mg capsuleThis study is performed on healthy volunteers..IRCT20200623047902N26Alborz Zagros company24
尚未招募
不适用
Study of absorption and elimination rate of Dimethyl Fumarate 240-mg capsule in comparison with Dimethyl Fumarate brand Capsule (Tecfidera®).Bioequivalence study.IRCT20200407046981N27Avicenna Pharmaceutical Company24